$733 Million is the total value of MARXE AUSTIN W & GREENHOUSE DAVID M's 202 reported holdings in Q3 2014. The portfolio turnover from Q2 2014 to Q3 2014 was 100.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
AEGR | Exit | Aegerion Pharmaceuticals, Inc. | $0 | – | -10,100 | -100.0% | -0.04% | – |
ANAD | Exit | ANADIGICS, Inc. | $0 | – | -546,318 | -100.0% | -0.06% | – |
DLIAQ | Exit | dELiA*s Corporation | $0 | – | -802,774 | -100.0% | -0.08% | – |
CALD | Exit | Callidus Software | $0 | – | -74,900 | -100.0% | -0.11% | – |
EDAP | Exit | EDAP TMS SA - ADR | $0 | – | -500,000 | -100.0% | -0.32% | – |
ISNS | Exit | Image Sensing Systems, Inc. | $0 | – | -859,646 | -100.0% | -0.36% | – |
DESTQ | Exit | Destination Maternity Corp. | $0 | – | -299,864 | -100.0% | -0.86% | – |
VPCO | Exit | Vapor Corporation | $0 | – | -1,555,968 | -100.0% | -0.98% | – |
TTPH | Exit | Tetraphase Pharmaceuticals | $0 | – | -810,000 | -100.0% | -1.38% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2014-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Ziopharm Oncology Inc (R/R) @4 | 6 | Q3 2014 | 9.0% |
Kopin Corporation | 6 | Q3 2014 | 3.0% |
CEVA, Inc. | 6 | Q3 2014 | 3.3% |
Ultra Clean Holdings, Inc. | 6 | Q3 2014 | 3.2% |
Broadwind Energy Inc. | 6 | Q3 2014 | 3.0% |
Pfsweb, Inc. | 6 | Q3 2014 | 3.5% |
ParkerVision, Inc. | 6 | Q3 2014 | 3.9% |
Adept Technology, Inc. | 6 | Q3 2014 | 3.1% |
OmniVision Technologies, Inc. | 6 | Q3 2014 | 2.5% |
Entropic Communications, Inc. | 6 | Q3 2014 | 2.5% |
View MARXE AUSTIN W & GREENHOUSE DAVID M's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
BROADWIND ENERGY, INC. | February 12, 2020 | 1,365,092 | 8.3% |
BROADWIND ENERGY, INC. | February 13, 2019 | 1,171,834 | 7.5% |
Carbon Energy Corp | February 13, 2019 | 706,549 | 9.2% |
Corium International, Inc. | February 13, 2018 | 2,268,443 | 6.3% |
Aldeyra Therapeutics, Inc. | February 10, 2017 | 912,610 | 7.3% |
Enservco Corp | February 10, 2017 | 3,750,000 | 7.6% |
ESSA Pharma Inc. | February 10, 2017 | 1,696,968 | 10.0% |
CVD EQUIPMENT CORP | August 06, 2015 | 288,700 | 4.7% |
CEVA INCSold out | February 04, 2015 | 0 | 0.0% |
hopTo Inc.Sold out | February 04, 2015 | 0 | 0.0% |
View MARXE AUSTIN W & GREENHOUSE DAVID M's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2020-02-12 |
SC 13G/A | 2019-02-13 |
SC 13G/A | 2019-02-13 |
SC 13G/A | 2018-02-13 |
SC 13G/A | 2018-02-13 |
SC 13G | 2018-02-13 |
SC 13G/A | 2017-02-10 |
SC 13G/A | 2017-02-10 |
SC 13G | 2017-02-10 |
SC 13G | 2017-02-10 |
View MARXE AUSTIN W & GREENHOUSE DAVID M's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.